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Abstract Aqueous extracts of cigarette smoke (CSE) can
oxidatively modify plasma low-density lipoprotein (LDL). The
aim of the present study was to elucidate the participation of
peroxynitrite in LDL oxidation. When LDL was incubated with
CSE, its oxidative modification was dependent on time and
concentration. It could be effectively prevented by vitamin E,
partially by superoxide dismutase, but hardly by catalase,
mannitol and metal chelators. CSE also increased the 3-
nitrotyrosine content in LDL. A similar increase of 3-nitrotyr-
osine occurred after incubation of LDL with a peroxynitrite
generating agent, 3-morpholinosydnonimine, thus suggesting that
prominent pro-oxidants in CSE are peroxynitrite-generating
species. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cigarette smoking is believed to be a major risk factor in
the development of atherosclerosis and related diseases, but
the exact mechanisms underlying this association remain to be
determined. Yokode et al. [1] have demonstrated that aqueous
extracts of cigarette smoke (CSE) can modify low-density
lipoprotein (LDL) in vitro and that the modi¢ed LDL can
be taken up e⁄ciently by macrophages to form foam cells.
They also showed that these changes can be prevented by
superoxide dismutase (SOD). Other reports have indicated
that the plasma in cigarette smokers is in an oxidative stress
condition [2^4] and has increased levels of antibody against
oxidized LDL [5,6]. Our previous paper reported an increase
in oxidatively modi¢ed LDL as well as lipid peroxides in the
plasma of Watanabe heritable hyperlipidemic (WHHL) rab-
bits injected with CSE [7]. These reports suggest that cigarette
smoke can generate oxidized LDL in vivo, as well as lead to
the development of atherosclerosis, because oxidized LDL has
been recognized as playing an important role in the develop-
ment of atherosclerosis [8,9].
Cigarette smoke is known to produce a high concentration
of free radicals such as superoxide anion, nitrogen oxides,
reactive aldehyde species, carbon monoxide, nitric oxide and
peroxynitrite [10]. These radicals in gas-phase cigarette smoke
are very short-lived in aqueous solution, but some active oxi-
dants or pro-oxidants capable of oxidizing LDL are likely to
remain. The possible active pro-oxidants in CSE have been
previously reported to be peroxynitrite-generating species hav-
ing an e¡ect similar to 3-morpholinosydnonimine (SIN-1)
[11].
In the present study, we attempted to identify the relatively
stable pro-oxidants in CSE, which can modify LDL. The chief
focus was to ascertain the presence of peroxynitrite or its pro-
oxidants by examining the presence of 3-nitrotyrosine (3-NT)
in apolipoprotein, apolipoprotein B, of modi¢ed LDL by liq-
uid chromatography-tandem mass spectrometry (LC-MS-
MS).
2. Materials and methods
2.1. Materials
The cigarettes used were the Frontier Lights brand (JT, Tokyo,
Japan) containing 1 mg of tar and 0.1 mg of nicotine per cigarette.
Cambridge ¢lters (Borgwaldt, Germany) were used to remove 99.9%
of all particles and nicotine from the cigarette smoke. Cholesterol
oxidase (EC 1.1.3.6; 18 U/mg) from Streptomyces sp., peroxidase
(EC 1.11.1.7; 134 U/mg) from horseradish, and cholesteryl ester hy-
drolase (EC 3.1.1.13; 144 U/mg) from Pseudomonas sp. were pur-
chased from Toyobo (Osaka, Japan), and homovanillic acid from
Tokyo Kasei (Tokyo, Japan). Vitamin E, vitamin C, D-mannitol,
uric acid, deferoxamine and D-(^)-penicillamine were purchased
from Nacalai Tesque (Kyoto, Japan), 2-(4-trimethylammoniophen-
yl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide chloride (TMA-
PTIO), SIN-1 and ethylenediamine-N,N,N,N-tetraacetic acid disodi-
um salt (EDTA) from Dojindo Lab. (Kumamoto, Japan), sodium
N,N-diethyl-dithiocarbamate (DDC) from Tokyo Kasei (Tokyo, Ja-
pan), SOD and catalase from Toyobo (Osaka, Japan), Dulbecco’s
phosphate-bu¡ered saline (PBS) from Nissui Pharmaceutical (Tokyo,
Japan) and authentic 3-NT from Sigma Chemical (St. Louis, MO,
USA). Other chemicals of analytical reagent grade were purchased
from Nacalai Tesque (Kyoto, Japan) and used without further puri-
¢cation. Water was puri¢ed with a Milli Q Jr. (Millipore, Tokyo,
Japan) and used to prepare eluents for the LC method.
2.2. Preparation of CSE
CSE was prepared by modi¢cation of the technique by previous
reports [1,12]. Brie£y, CSE was prepared by bubbling into PBS
(1 ml/three cigarettes) a stream of smoke from which tars and nicotine
had been removed by gentle aspiration through a Cambridge ¢lter; it
took approximately 5 min to consume one cigarette. The CSE
solution, with a pH of approximately 7.0, was sterilized through a
0.22-Wm ¢lter (Millipore, Tokyo, Japan). This CSE solution was re-
garded as the highest concentration (100%) and was diluted to various
concentrations with PBS when necessary. The quality of the CSE
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solution prepared was assessed by measuring the absorbance at 302
nm, which is the speci¢c absorption spectrum of peroxynitrite, and
solutions with an O.D. value of more than 3.0 were used.
2.3. Animals
Male WHHL rabbits (7 months old, 2.5^2.8 kg) were obtained
from our colony bred by mating pairs of homozygous WHHL rabbits
kindly supplied by Dr. T. Kita (Department of Geriatric Medicine,
Faculty of Medicine, Kyoto University, Japan), originally obtained
from Dr. Y. Watanabe (Institute for Experimental Animals, School
of Medicine, Kobe University, Japan).
2.4. Preparation of LDL
Blood was drawn from WHHL rabbits into tubes containing
EDTA at a ¢nal concentration of 1 mg/ml for anticoagulation and
prevention of autoxidation of lipoproteins. The plasma was separated
by centrifugation (1500Ug for 10 min) from the blood, and stored at
4‡C. Native LDL (N-LDL, d = 1.019^1.063 g/ml) was sequentially
isolated by ultracentrifugation from the plasma samples [13]. A Beck-
man TL-100E ultracentrifuge was used to separate N-LDL with a
TLA 110.3 ¢xed-angle rotor at 40 000Ug for 330 min at 4‡C. The
isolated N-LDL was dialyzed against PBS at 4‡C for removal of
EDTA and used as experimental samples. The protein contents in
LDLs were measured by the method of Lowry et al. [14].
2.5. Oxidative modi¢cation of LDL by CSE
N-LDL (200 Wg of protein/300 Wl) was incubated with 30% concen-
tration of CSE in the absence or presence of various concentrations of
antioxidants, reactive oxygen scavengers and metal chelators at 37‡C
for 24 h. The agents used were vitamin E (1036^1034 M) as a lipid-
soluble antioxidant, vitamin C (1036^1034 M) as a water-soluble anti-
oxidant, SOD (100^1000 U/ml) as a superoxide scavenger, catalase
(75^750 U/ml) as a hydrogen peroxide scavenger, TMA-PTIO
(1036^1034 M) as a nitric oxide scavenger, D-mannitol (1036^1034
M) as a hydroxyl radical scavenger, uric acid (1036^1034 M) as a
singlet oxygen scavenger, EDTA (1036^1034 M) as a non-selective
metal chelator, deferoxamine as an iron chelator, DDC (1036^1034
M) as a copper chelator, and D-(^)-penicillamine (1036^1034 M) as a
copper chelator. After incubation, an aliquot (40 Wl) of each reaction
medium was immediately used to assess modi¢ed LDL by an LDL-
subfraction assay method using anion-exchange LC (AE-LC) and
another aliquot (150 Wl) of the medium was frozen at 320‡C for
measurement of thiobarbituric acid-reactive substances (TBARS) by
a £uorometric method according to Yagi [15].
2.6. LDL-subfraction assay method using AE-LC
The LDL-subfraction assay method by AE-LC was used to assess
the modi¢cation of LDL, as reported in previous papers [12,16].
Brie£y, the pumps (all from Japan Spectroscopic, Tokyo, Japan)
used were two PU-980 intelligent pumps for delivering eluents and
two 880-PU intelligent pumps for delivering cholesterol reagent and
sodium hydroxide solution. ProtEX-DEAE (particle diameter 5 Wm;
column size 50U4.6 mm I.D.) columns, which are anion-exchange
columns having DEAE groups, were kindly donated by Mitsubishi
(Tokyo, Japan). The eluents used were as follows: eluent A, 20 mM
sodium phosphate bu¡er (pH 7.0) containing 1U1033 M EDTA;
eluent B, 500 mM sodium chloride containing 1U1033 M EDTA.
The £ow rate was maintained at 1.0 ml/min. The separation was
carried out at 25‡C using a water bath (Thermo Minder Lt-100, Tai-
tec, Saitama, Japan). The modi¢ed LDLs were separated by stepwise
elution with 43, 52, 60 and 100% eluent B. Those fractions were
labeled as LDL1, LDL2 and LDL3, respectively. The total cholesterol
level of each subfraction was evaluated by enzymatic postcolumn re-
action with the cholesterol reagent described below. Lipoproteins were
detected with an excitation wavelength of 325 nm and an emission
wavelength of 420 nm using an RF-535 spectro£uorimeter (Shimadzu,
Kyoto, Japan). Chromatographic data were collected with a CBM-
10A interface, transmitted to COMPAQ computer, and integrated
using CLASS-LC10 software version 1.41 (Shimazu, Kyoto, Japan).
For the enzymatic postcolumn reaction, the cholesterol reagent,
which includes cholesteryl ester hydrolase (5 Wg/ml, 0.7 U/ml), choles-
terol oxidase (20 Wg/ml, 0.4 U/ml), peroxidase (50 Wg/ml, 7 U/ml) and
homovanillic acid (500 mg/ml), was dissolved in 20 mM sodium phos-
phate bu¡er (pH 7.0) containing 0.2% Triton X-100, and delivered at
a £ow rate of 0.5 ml/min. A knitted reaction coil (15 mU0.5 mm I.D.)
immersed in the water bath (Thermo Minder, Lt-100) at 45‡C was
used as the enzymatic reactor. After the enzymatic reaction, a 0.1-M
sodium hydroxide solution was delivered into a knitted reaction coil
(0.5 mU0.5 mm I.D.) at a £ow rate of 0.5 ml/min to alkalize the
e¥uent, because the stable and higher £uorescence can be detected
at more than pH 10.
Typical chromatograms of N-LDL and LDL modi¢ed by CSE
(30%, 24 h) are shown in Fig. 1. The degree of modi¢cation in the
LDL after incubation was evaluated by the increase in the ratio of
LDL3 to LDL2.
2.7. Comparison of LDL modi¢cation by CSE and SIN-1
N-LDL (200 Wg of protein/300 Wl) was modi¢ed by incubation with
various concentrations of CSE (15^85%) at 37‡C for 24 h or SIN-1
(0.1^1.0 mM), a peroxynitrite generating agent, at 37‡C for 6 h. Also,
N-LDL (200 Wg of protein/300 Wl) was modi¢ed by incubation with
CSE solution (30%) or SIN-1 (0.5 mM) at 37‡C for various periods of
time (0.5^24 h). After the incubation, an aliquot of the reaction me-
dium was immediately assessed for the oxidative modi¢cation by the
LDL-subfraction assay method and measured for TBARS levels. An-
other aliquot of the medium containing modi¢ed LDL was used for
the lipid extraction with ethanol:ether (3:1, v/v), and the residue con-
taining apolipoprotein B was hydrolyzed with 6 M hydrochloric acid
for 4 h at 110‡C. After removal of hydrochloric acid from the hydro-
lysate, the residue was dissolved in distilled water and used for iden-
ti¢cation and determination of 3-NT.
2.8. Identi¢cation of 3-NT in modi¢ed LDL
The identi¢cation of 3-NT in modi¢ed LDL was performed by
LC-MS-MS with electrospray ionization. A Finningan TSQ 7000
mass spectrometer (Thermo Quest, Sydney, Australia) was coupled
to an HP 1050 LC system (Agilent Technologies, Hachioji, Japan).
The analytical column was an ODS-Hypersil (100U2.1 mm I.D.,
3 Wm, Agilent Technologies, Hachioji, Japan) at a £ow rate of 0.2
ml/min and mobile phase was 10% (v/v) methanol in 0.1% (v/v) formic
acid. The MS-MS conditions were as follows: capillary temperature,
250‡C; sheath gas, 70 psi (20 U auxiliary gas); needle potential, 4.5 kV
(negative); collision o¡set, 23 eV. Identi¢cation of the 3-NT in the
sample was performed by comparison with authentic 3-NT.
2.9. Determination of 3-NT in modi¢ed LDL
The determination of 3-NT in modi¢ed LDL was performed by LC
with coulometric electrochemical array detection (LC-ECD) (Coulo-
chem-II, ESA, Chelmsford, MA, USA). The voltage of the guard cell,
Model 5020, was set at 800 mV and those of the ¢rst and second
electrodes of analytical cell, Model 5010, were set at 550 mV and at
750 mV. The analytical column was a 5-Wm Cosmosil 5C18-AR-II
(150 U4.6 mm I.D.; Nacalai Tesque, Kyoto, Japan) equipped with
a guard column (10U4.6 mm I.D.) and the mobile phase was 20 mM
sodium phosphate bu¡er, pH 3.07, including 5% (v/v) methanol. The
£ow rate was 1 ml/min and the temperature was set at 25‡C. Quanti-
tation of the 3-NT was performed by comparison of the peak area to
that of the standard, authentic 3-NT.
Fig. 1. Chromatograms of N-LDL and modi¢ed LDL incubated
with CSE (30%, 24 h) from LDL-subfraction assay using AE-LC
method. LDL1, LDL2, and LDL3 represent subfractions separated
by this method. The increase in the ratio of LDL3 to LDL2 was
used as an indicator of oxidative modi¢cation of LDL. The LC
conditions are described in Section 2.
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2.10. Statistics
The results are expressed as the mean þ S.D. of triplicate determi-
nations in the experiment using a single CSE preparation and a single
LDL preparation. For Table 1, statistical analysis was performed
using unpaired Student’s t-test between the data from the non-treated
LDL and CSE-treated LDL (control), and then using Bonferroni
multiple-range test among the data from the control and LDL treated
with antioxidants at various concentrations. These statistical analyses
were performed using the Stat View software package (SAS Institute
Inc., Cary, NC, USA). A di¡erence was considered signi¢cant when
P6 0.05.
3. Results
3.1. E¡ects of various antioxidants, reactive oxygen scavengers
and metal chelators on oxidative modi¢cation of LDL by
CSE
The degree of modi¢cation of LDL was estimated by the
percentages of LDL2 and LDL3 separated by AE-LC and
TBARS levels, as an index for lipid peroxidation (Table 1).
In the control (LDL+CSE), where N-LDL was incubated
with CSE without antioxidant at 37‡C for 24 h, LDL2 sig-
ni¢cantly (12.0%) decreased and LDL3 signi¢cantly (39.6%)
increased compared with those in the non-treated LDL, where
N-LDL was incubated without CSE at 37‡C for 24 h. The
TBARS level in the control signi¢cantly (209%) increased
compared with that in non-treated LDL. These changes in
the control were signi¢cantly prevented by 59.6, 11.5 and
77.1% in LDL1, LDL2 and TBARS, P6 0.05, respectively,
at 1035 M and 78.8, 31.7, and 105.5% in LDL2, LDL3 and
TBARS, P6 0.05, respectively, at 1034 M of vitamin E, and
by 57.7, 11.5 and 13.6% in LDL2, LDL3 and TBARS,
P6 0.05, respectively, at 1034 M of vitamin C. The reactive
oxygen scavengers did not prevent the oxidative modi¢cation
of LDL by CSE, except that SOD was signi¢cantly prevented
at 1000 U/ml by 51.9 and 18.7% in LDL2 and LDL3,
P6 0.05, respectively. No e¡ect on the oxidative modi¢cation
of LDL was found with various metal chelators, such as
EDTA, deferoxamine, DDC and D-(^)-penicillamine (data
not shown).
3.2. Identi¢cation of 3-NT in modi¢ed LDL
The production of 3-NT in LDL incubated with CSE was
established by the method of LC-MS-MS. The mode exam-
ined was negative ionization with selective reaction monitor-
ing (SRM). The parent ions (M^H) had a m/z 224.9. One
daughter ion selected had a mass of m/z 163.1 and the other
daughter ion selected had a mass of m/z 134.6, detection at m/z
163.1 was more sensitive. Representative SRM ion chromato-
grams of 3-NT in N-LDL incubated with or without CSE as
well as authentic 3-NT are shown in Fig. 2. A single peak of
3-NT was detected only slightly, but markedly increased in
LDL after incubation with CSE (85%, 24 h). As a further
test of the selectivity of 3-NT detection by LC-MS-MS, au-
thentic 3-NT was added to the N-LDL sample (Fig. 2). The
Table 1
E¡ect of antioxidants and reactive oxygen scavengers on oxidative modi¢cation of LDL by CSE
Drug Concentration LDL2 (% of TC) LDL3 (% of TC) TBARS (nmol/mg TC)
Non-treated LDL 41.3 þ 0.2 35.1 þ 0.2 0.113 þ 0.006
Control (LDL+CSE) 36.1 þ 0.2V 49.0 þ 0.2V 0.349 þ 0.004V
Vitamin E 1036 M 36.6 þ 0.4 49.5 þ 0.2 0.261 þ 0.004*
1035 M 39.2 þ 0.7* 47.4 þ 0.7* 0.167 þ 0.006*
1034 M 40.2 þ 1.1* 44.6 þ 1.0* 0.100 þ 0.007*
Vitamin C 1036 M 37.5 þ 0.4 48.8 þ 0.3 0.377 þ 0.012
1035 M 38.4 þ 0.3* 48.1 þ 0.4 0.351 þ 0.006
1034 M 39.1 þ 0.3* 47.4 þ 0.1* 0.317 þ 0.007*
SOD 100 U/ml 36.6 þ 0.2 48.6 þ 0.4 0.346 þ 0.025
500 U/ml 37.2 þ 0.6 48.1 þ 0.9 0.329 þ 0.002
1000 U/ml 38.8 þ 0.1* 46.4 þ 0.3* 0.321 þ 0.012
Catalase 75 U/ml 36.1 þ 0.2 48.9 þ 0.3 0.341 þ 0.015
375 U/ml 36.0 þ 0.1 49.4 þ 0.3 0.342 þ 0.017
750 U/ml 35.9 þ 0.1 49.2 þ 0.2 0.340 þ 0.020
TMA-PTIO 1036 M 36.2 þ 0.3 48.9 þ 0.3 0.338 þ 0.028
1035 M 36.1 þ 0.3 48.9 þ 0.3 0.352 þ 0.009
1034 M 36.1 þ 0.1 49.4 þ 0.3 0.335 þ 0.019
D-Mannitol 1036 M 36.1 þ 0.2 49.2 þ 0.4 0.326 þ 0.005
1035 M 36.1 þ 0.3 49.2 þ 0.3 0.341 þ 0.012
1034 M 36.1 þ 0.3 49.3 þ 0.3 0.350 þ 0.014
Uric acid 1036 M 36.2 þ 0.2 49.0 þ 0.6 0.341 þ 0.026
1035 M 36.0 þ 0.3 49.2 þ 0.2 0.345 þ 0.025
1034 M 36.1 þ 0.3 48.9 þ 0.2 0.348 þ 0.020
Each value represents the mean þ S.D. of triplicate determinations in the experiment using a single CSE preparation and a single LDL prepara-
tion. VP6 0.05, non-treated LDL and the control; *P6 0.05, control vs. agent-treated LDLs.
Fig. 2. Representative SRM ion chromatograms of the hydrolysates
of apolipoprotein B in various LDLs by LC-MS-MS. Hydrolysate
samples were prepared as described in Section 2. A 10-Wl portion of
a sample was injected onto the column. Modi¢ed LDL: N-LDL in-
cubated with 85% CSE at 37‡C for 24 h. N-LDL+authentic 3-NT:
2 WM authentic 3-NT was added in the hydrolysate sample of apoli-
poprotein B of N-LDL.
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peak identi¢ed as 3-NT in the modi¢ed LDL sample by CSE
had the same retention time as the authentic 3-NT added to
the N-LDL sample.
3.3. E¡ects of incubation time on LDL modi¢cation and
3-NT production by CSE and SIN-1
Fig. 3 shows the time course of degree of oxidative mod-
i¢cation and 3-NT contents in the LDL incubated with CSE
(30%) or SIN-1 (0.5 mM) at 37‡C. SIN-1 gradually increased
the 3-NT contents as well as the degree of oxidative modi¢-
cation in the LDL, as assessed by the decreased LDL2 level
and the increased LDL3 level. Both reactions were terminated
after 3 h at the concentration of 0.5 mM. Similar changes
were also detected in the case of CSE, but the reaction rate
was much slower than that of SIN-1 and the reaction was
terminated after 6 h at the concentration of 30%. However,
the production of TBARS by CSE and SIN-1 was terminated
after 3 and 1 h, respectively, somewhat faster than the changes
in the LDL subfraction and nitration. The activities of nitra-
tion and oxidative modi¢cation were preserved in both CSE
and SIN-1 solutions for 1 month or more at 320‡C.
3.4. E¡ects of concentrations of CSE or SIN-1 on
LDL modi¢cation and 3-NT production
Fig. 4 shows the concentration-related increase in 3-NT
content and progress of oxidative modi¢cation in the LDL
incubated with CSE or SIN-1 for 24 or 6 h, respectively.
CSE and SIN-1 caused an increase in the 3-NT content, as
well as a decrease in the LDL2 level and an increase in the
LDL3 level in a concentration-dependent manner. Also, the
TBARS levels linearly increased and reached a plateau at 50%
CSE and 0.5 mM SIN-1, respectively. On the basis of the
concentration^production curves of 3-NT, the nitration po-
tency of CSE was calculated as being roughly equivalent to
that of 0.2 mM SIN-1.
4. Discussion
The present study demonstrated that CSE can cause nitra-
tion of tyrosine residues in apolipoprotein B in LDL. The 3-
NT produced is used as a biomarker of nitrative pathology
caused by peroxynitrite and appears to be a stable and speci¢c
footprint, because peroxynitrite reacts with tyrosine to yield 3-
Fig. 3. E¡ect of incubation time on oxidative modi¢cation of LDL and 3-NT formation by CSE (closed symbols) and SIN-1 (open symbols).
N-LDL (200 Wg) was incubated with CSE (30%) or SIN-1 (0.5 mM) for various periods of time at 37‡C in PBS, pH 7.4. The degree of oxida-
tive modi¢cation of LDL was assessed by LDL-subfraction assay for the percentage of LDL2 (squares) and LDL3 (circles), and by the AE-LC
method for TBARS levels (triangles). The 3-NT formation was assessed by 3-NT contents (crosses) in apolipoprotein B of LDL, measured by
the LC-ECD method. Each data point represents the mean of triplicate determinations in the experiment using a single CSE preparation and a
single LDL preparation.
Fig. 4. E¡ect of concentration of CSE (closed symbols) and SIN-1 (open symbols) on oxidative modi¢cation of LDL and 3-NT formation. N-
LDL (200 Wg) was incubated with CSE (15^85%) for 24 h and SIN-1 (0.1^1.0 mM) for 6 h at 37‡C in PBS, pH 7.4. The degree of oxidative
modi¢cation of LDL was assessed by LDL-subfraction assay for the percentage of LDL2 (squares) and LDL3 (circles), and by AE-LC method
for TBARS levels (triangles). The 3-NT formation was assessed by 3-NT contents (crosses) in apolipoprotein B of LDL measured by the LC-
ECD method. Each data point represents the mean of triplicate determinations in the experiment using a single CSE preparation and a single
LDL preparation.
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NT. The nitration of tyrosine to 3-NT by peroxynitrite may
be one of the important mechanisms regarding disease path-
ology. Many reports have demonstrated that increased 3-NT
formation is associated with Alzheimer’s disease [17], amyo-
trophic lateral sclerosis [18], Parkinson’s disease [19], ischemia
[20], as well as a number of atherosclerosis and relative dis-
eases [21^24].
In order to know the property of oxidants in CSE, we ¢rst
examined the e¡ects of antioxidants, reactive oxygen scav-
engers and chelators on oxidative modi¢cation of LDL by
CSE. We previously developed an LDL-subfraction assay
method using AE-LC for measuring oxidized LDL [16] and
used this method to estimate oxidatively modify LDL, which
was prepared by incubation of N-LDL with CSE in vitro [12].
In the present study, metal chelators, such as EDTA, deferox-
amine, DDC or D-(^)-penicillamine, could not prevent the
oxidative modi¢cation of LDL by CSE at all, indicating
that catalytic oxidation through metal ions such as iron or
copper in CSE was not involved in the oxidative modi¢cation
of LDL. Additionally, hydrogen peroxide, nitric oxide, hy-
droxyl radical and singlet oxygen do not appear to be in-
volved in this oxidative modi¢cation by CSE, because the
respective scavenger, catalase, TMA-PTIO, D-mannitol and
uric acid, did not signi¢cantly prevent the oxidative modi¢ca-
tion, although SOD was slightly e¡ective. From these results,
we concluded that the oxidants in CSE are capable of not
only oxidation but also nitration of LDL; that is, the property
of peroxynitrite. Cigarette smoke has been shown to contain a
considerable concentration of peroxynitrite that would appear
to be produced by reaction of nitric oxide and superoxide in
the gas phase [10]. Muller et al. [25] have also reported that
peroxynitrite is formed in even aqueous CSE solution together
with nicotine and tars, although this could not directly be
certi¢ed. Peroxynitrite is converted within seconds to nitrite
in aqueous solution at pH 7.4 [26]. Nevertheless, it has been
demonstrated that the ability of CSE to modify LDL can be
preserved for 1 month or more at 320‡C [7]. Thus, the active
oxidants in CSE seem to be relatively stable pro-oxidants,
probably peroxynitrite-generating substances such as SIN-1.
Both CSE and SIN-1 increased the 3-NT contents and the
degree of modi¢cation in the LDL in a concentration-depen-
dent manner. It has been known that a SIN-1 solution pro-
duces peroxynitrite via one-electron oxidation by molecular
oxygen to produce peroxide and the subsequent release of
nitric oxide [27] and its decomposition is essentially completed
after 3 h [26]. In the present study, the nitration as well as
modi¢cation of LDL by SIN-1 terminated after 3 h, as might
have been anticipated, while the termination time of CSE was
6 h. These results suggested that CSE gradually releases per-
oxynitrite in a similar manner to SIN-1 but with a much
slower reaction rate. Petruzzelli et al. [28] have reported the
increased production of 3-NT in the plasma protein of ciga-
rette smokers. However, there has been no evidence for the
production of 3-NT in LDL treated with cigarette smoke in
vitro and vivo. In the present study, the presence of 3-NT in
apolipoprotein B of LDL due to CSE was identi¢ed by LC-
MS-MS and measured by LC-ECD. The detection of 3-NT by
LC-MS-MS is more selective but less sensitive than the detec-
tion by LC-ECD [29]. This is the ¢rst report showing the
participation of peroxynitrite in the production of oxidatively
modi¢ed LDL by CSE.
This work shows that peroxynitrite is a major active oxi-
dant involved in LDL modi¢cation by CSE and that it arises
from peroxynitrite-generating species soluble in CSE.
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